MOESM1 of Improved co-registration of ex-vivo and in-vivo cardiovascular magnetic resonance images using heart-specific flexible 3D printed acrylic scaffold combined with non-rigid registration
Creators: name: Whitaker, John
name: Radhouene Neji
name: Byrne, Nicholas
name: Puyol-Antón, Esther
name: Mukherjee, Rahul
name: Williams, Steven
name: Chubb, Henry
name: O’Neill, Louisa
name: Orod Razeghi
name: Connolly, Adam
name: Kawal Rhode
name: Niederer, Steven
name: King, Andrew
name: Tschabrunn, Cory
name: Anter, Elad
name: Nezafat, Reza
name: Bishop, Martin
name: O’Neill, Mark
name: Razavi, Reza
name: Roujol, Sébastien
Publisher: name: figshare
Year: 2019
Subjects: subject: Biophysics
subject: Biochemistry
subject: Space Science
subject: Medicine
subject: Cell Biology
subject: Genetics
subject: FOS: Biological sciences
subject: FOS: Biological sciences
subject: Physiology
subject: Pharmacology
subject: Evolutionary Biology
subject: Science Policy
subject: 69999 Biological Sciences not elsewhere classified
subject: Developmental Biology
subject: Cancer

description: Additional file 1: Supplementary data. Figure S1. Illustration of papillary muscle identification. Panel A: Short axis view of left ventricle at mid-cavity level. The papillary muscles are clearly separated from the left ventricular wall and were therefore not included in the LV segmentation at this level. Arrows indicate contrast between the papillary muscle body and the LV wall. Panel B: Short axis view on ex-vivo imaging at same level as panel A. In the ex-vivo condition the papillary muscles are pushed against the LV wall however a clear rim of contrast is visible between the papillary muscles and the LV wall so in the ex-vivo segmentation were not included in the LV wall at this level, reflecting the segmentation in the in-vivo imaging. Arrows indicate contrast between the papillary muscle body and the LV wall. Panel C: Short axis view of the LV below the level shown in panel A. At this level the papillary muscle is continuous with the LV wall and at this level was included in the LV segmentation. Panel D: Short axis view on ex-vivo imaging at the same level as panel C. There is no contrast between the bulge of the papillary muscles and the LV wall as they are continuous at this level, and were therefore included in the LV segmentation at reflecting the segmentation in the in-vivo imaging. Increased signal intensity around the endocardial surface in the ex-vivo condition may be contributed to by leaching of gadolinium into the saline adjacent the hearts were bathed in during ex-vivo imaging. Figure S2. in-vivo imaging. Panel A: Histogram of signal intensities within in-vivo segmented myocardium. Panel B: 3D volume rendering of segmented LV tissue (dark blue), aorta (gold) and scar (red) superimposed on SAX and LAX slices of in-vivo imaging. Panel C: Short axis slice of in-vivo imaging at mid-cavity level showing anteroseptal scar. Panel D: Corresponding slice of in-vivo imaging as panel C with segmentation of scar superimposed (red). Figure S3. Ex-vivo MR imaging and segmentation (imaging information outside of segmented LV myocardium including that from adherent pericardium removed for clarity). Panels A to C: Short axis (SAX) (A) and two long axis (LAX) (B / C) views of contrast enhanced ex-vivo imaging. Panels D to F: Same images as panels A to C with segmented scar (red) superimposed. Panel G: Signal intensity (SI) histogram within segmented myocardium. Red dashed-dotted line is mean SI within dense scar, black solid line is scar threshold, blue dashed line is mean SI within healthy tissue. Panel H: 3D volume rendering of segmented LV tissue (dark blue), aorta (gold) and scar (red) superimposed on SAX and LAX slices of ex-vivo imaging. Figure S4. Paired short axis slices from in-vivo (top) and ex-vivo (bottom) imaging using a rigid 3D printed scaffold. White arrow identifies rigid 3D printed scaffold, which generates a signal void in the imaging. Red arrow indicates the incision required for insertion of the rigid scaffold. Yellow arrow identifies scar in the in-vivo and ex-vivo imaging. Figure S5. Linear regression between volume of scar identified on in-vivo imaging using a full width at half maximum threshold and ex-vivo imaging. (DOCX 15892 kb)